Rocket One Inc. (RKTO)
NASDAQ: RKTO · Real-Time Price · USD
1.115
-0.365 (-24.66%)
At close: Jun 12, 2026, 4:00 PM EDT
1.120
+0.005 (0.45%)
After-hours: Jun 12, 2026, 7:59 PM EDT
Rocket One Employees
As of December 31, 2025, Rocket One had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,895,310
Market Cap
21.33M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - | 2 | 1 |
| Dec 31, 2024 | 3 | 0 | - | 2 | 1 |
| Dec 31, 2023 | 3 | 0 | - | 2 | 1 |
| Dec 31, 2022 | 3 | -2 | -40.00% | 2 | 1 |
| Dec 31, 2021 | 5 | 1 | 25.00% | 4 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 390,000 |
| Johnson & Johnson | 138,200 |
| AbbVie | 57,000 |
| Eli Lilly and Company | 50,000 |
| Retractable Technologies | 201 |
| Celularity | 115 |
| Atossa Therapeutics | 16 |
| Quantum Cyber | 13 |
RKTO News
- 1 day ago - These space stocks are not SpaceX—but they're blasting off this week in the wake of IPO fever - Fast Company
- 10 days ago - ROCKET ONE APPOINTS MAJOR GENERAL MALCOLM B. FROST (RET. - PRNewsWire
- 12 days ago - Rocket One Appoints Dr. Supriyo Bandyopadhyay as Lead Technical Advisor of AI Nanomagnetic Technology - PRNewsWire
- 17 days ago - Hoth Therapeutics Becomes Rocket One Inc. (Nasdaq: RKTO), Targeting the Space Economy with Next-Generation Nanomagnetic AI Chip Technology and Ultra-Low-Power, Radiation-Tolerant Computing for Space and Defense Applications - PRNewsWire
- 4 years ago - Hoth Therapeutics Granted 180 Day Extension by Nasdaq to Regain Compliance with Bid Price Rule - PRNewsWire
- 6 years ago - Hoth Therapeutics' Scientific Advisory Board Member and Inventor of Licensed Novel Peptide COVID-19 Therapeutic, Dr. Michael Peters, Publishes White Paper - PRNewsWire